| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $0.69 (Beat by $0.06) |
| EPS GAAP Actual | $0.69 (Beat by $0.06) |
| Revenue Actual | $0.049863B |
| Revenue Surprise | Beat by $49.863M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.76 |
| EPS GAAP Estimate | $0.76 |
| Revenue Estimate | $0.055575B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 3.5 | 12 | 3.5 | 3.5 | 1 |
| Dec 2026 | 3.04 | 13.82 | 3.04 | 3.04 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.69 | -0.07 | 0.049863B | 54.33% | -5.38M |
| FQ2 2025 (Jun 2025) | 0.67 | -0.13 | 0.044398B | -10.34% | -11.41M |
| FQ1 2025 (Mar 2025) | 0.67 | -0.08 | 0.046407B | -7.25% | -7.86M |
| FQ4 2024 (Dec 2024) | 0.34 | -0.28 | 0.050371B | -0.3% | -1.29M |
| FQ3 2024 (Sep 2024) | 0.22 | -0.35 | 0.022774B | -116.69% | -27.72M |
| FQ2 2024 (Jun 2024) | 0.33 | -1.01259 | 0.04899B | 1.84% | -37.37M |
| FQ1 2024 (Mar 2024) | 0.53 | 0.53 | 0.049773B | 1.54% | 49.77M |
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 0.050521B | 2.13% | 50.52M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.76
Consensus Revenue Estimates
0.055575B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.77 | -- | 0.77 | 0.77 | 1 |
| FQ3 2026 (Sep 2026) | 0.82 | 15.85 | 0.82 | 0.82 | 1 |
| FQ2 2026 (Jun 2026) | 0.76 | 11.84 | 0.76 | 0.76 | 1 |
| FQ1 2026 (Mar 2026) | 0.69 | 2.9 | 0.69 | 0.69 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ3 2026 (Sep 2026) | 0.06B | 13.2 | 0.06B | 0.06B | 1 |
| FQ2 2026 (Jun 2026) | 0.06B | 20.68 | 0.06B | 0.06B | 1 |
| FQ1 2026 (Mar 2026) | 0.05B | 14.47 | 0.05B | 0.05B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
6
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.76 | 0.69 | -0.07 | -10.14% |
| FQ2 2025 (Jun 2025) | 0.8 | 0.67 | -0.13 | -19.4% |
| FQ1 2025 (Mar 2025) | 0.75 | 0.67 | -0.08 | -11.94% |
| FQ4 2024 (Dec 2024) | 0.62 | 0.34 | -0.28 | -82.35% |
| FQ3 2024 (Sep 2024) | 0.57 | 0.22 | -0.35 | -159.09% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.33 | -1.01259 | -306.85% |
| FQ1 2024 (Mar 2024) | 0.53 | 0.53 | 100% | |
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.06B | $0.05B | $-5.38M | -10.79% |
| FQ2 2025 (Jun 2025) | $0.06B | $0.04B | $-11.41M | -25.7% |
| FQ1 2025 (Mar 2025) | $0.05B | $0.05B | $-7.86M | -16.93% |
| FQ4 2024 (Dec 2024) | $0.05B | $0.05B | $-1.29M | -2.56% |
| FQ3 2024 (Sep 2024) | $0.05B | $0.02B | $-27.72M | -121.7% |
| FQ2 2024 (Jun 2024) | $0.09B | $0.05B | $-37.37M | -76.28% |
| FQ1 2024 (Mar 2024) | $0B | $0.05B | $49.77M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.05B | $50.52M | 100% |